Send me a link:

*Text messaging rates may apply.

 Dow Down 0.72% Nasdaq Down 0.50%

Celladon Corporation (CLDN)

-NasdaqGM
12.58 Down 0.72(5.41%) 3:59PM EDT
Prev Close:13.30
Open:13.05
Bid:10.50 x 100
Ask:15.95 x 2700
1y Target Est:16.50
Beta:N/A
Next Earnings Date:N/A
Day's Range:12.36 - 13.23
52wk Range:7.45 - 17.16
Volume:102,072
Avg Vol (3m):113,029
Market Cap:232.73M
P/E (ttm):N/A
EPS (ttm):-7.56
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CLDN

Comparison

Symbol% ChgMkt Cap
CLDNDown 5.41%232.73M
ACTCDown 5.33%212.82M
ABIODown 1.39%29.83M
GSKDown 2.96%116.85B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.84
Quarterly EPS Est (Jun-14) :-0.39
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celladon Corporation, a clinical-stage biotechnology company, focuses on developing treatments for heart failure, diabetes, and neurodegenerative diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback